Credit Suisse’s Chimerix, Inc. CMRX Stock Holding History

Credit Suisse’s Portfolio CMRX Stock Details CMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$99.6K	Sell	94,000 -40,000	-30%	-$41.6K	﹤0.01%	2932
2023 Q4	$129K	Sell	134,000 -65,200	-33%	-$63.1K	﹤0.01%	3016
2023 Q3	$191K	Sell	199,200 -324,800	-62%	-$354K	﹤0.01%	3034
2023 Q2	$634K	Hold	524,000	–	–	﹤0.01%	2658
2023 Q1	$660K	Sell	524,000 -3	-0%	-$5	﹤0.01%	2577
2022 Q4	$975K	Sell	524,003 -97,506	-16%	-$191K	﹤0.01%	2361
2022 Q3	$1.2M	Buy	621,509 +300,496	+94%	+$674K	﹤0.01%	2206
2022 Q2	$667K	Buy	321,013 +5,847	+2%	+$18.8K	﹤0.01%	2655
2022 Q1	$1.44M	Buy	315,166 +74,585	+31%	+$416K	﹤0.01%	2298
2021 Q4	$1.55M	Buy	240,581 +194,207	+419%	+$1.16M	﹤0.01%	2985
2021 Q3	$288K	Buy	46,374 +3,665	+9%	+$25.2K	﹤0.01%	4101
2021 Q2	$341K	Buy	+42,709	New	+$355K	﹤0.01%	4053
2021 Q1	–	Sell	-19,572	Closed	-$95K	–	4615
2020 Q4	$95K	Buy	+19,572	New	+$71K	﹤0.01%	4187
2019 Q4	–	Sell	-167,906	Closed	-$394K	–	4367
2019 Q3	$394K	Buy	+167,906	New	+$485K	﹤0.01%	3575
2019 Q2	–	Sell	-11,400	Closed	-$24K	–	4262
2019 Q1	$24K	Buy	+11,400	New	+$26K	﹤0.01%	3937
2018 Q3	–	Sell	-15,459	Closed	-$74K	–	4036
2018 Q2	$74K	Sell	15,459 -3,739	-19%	-$17.9K	﹤0.01%	3864
2018 Q1	$100K	Buy	19,198 +1,318	+7%	+$6.68K	﹤0.01%	3798
2017 Q4	$83K	Sell	17,880 -49,245	-73%	-$234K	﹤0.01%	3860
2017 Q3	$352K	Buy	67,125 +48,357	+258%	+$238K	﹤0.01%	3670
2017 Q2	$102K	Sell	18,768 -10,463	-36%	-$55K	﹤0.01%	3719
2017 Q1	$187K	Sell	29,231 -8,651	-23%	-$49.1K	﹤0.01%	3631
2016 Q4	$173K	Sell	37,882 -7,339	-16%	-$34.6K	﹤0.01%	3849
2016 Q3	$250K	Sell	45,221 -3,234	-7%	-$14.8K	﹤0.01%	3726
2016 Q2	$190K	Buy	48,455 +331	+0.7%	+$1.64K	﹤0.01%	3891
2016 Q1	$246K	Sell	48,124 -1,213	-2%	-$7.92K	﹤0.01%	3598
2015 Q4	$442K	Buy	49,337 +26,937	+120%	+$970K	﹤0.01%	3472
2015 Q3	$856K	Sell	22,400 -50,158	-69%	-$2.48M	﹤0.01%	2946
2015 Q2	$3.35M	Buy	72,558 +29,962	+70%	+$1.2M	﹤0.01%	2108
2015 Q1	$1.61M	Buy	42,596 +10,518	+33%	+$418K	﹤0.01%	2579
2014 Q4	$1.29M	Buy	32,078 +3,629	+13%	+$123K	﹤0.01%	2917
2014 Q3	$785K	Sell	28,449 -11,845	-29%	-$288K	﹤0.01%	3272
2014 Q2	$885K	Buy	40,294 +21,602	+116%	+$429K	﹤0.01%	3400
2014 Q1	$427K	Sell	18,692 -230	-1%	-$4.64K	﹤0.01%	3829
2013 Q4	$286K	Buy	+18,922	New	+$302K	﹤0.01%	4110

Other funds holding CMRX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Credit Suisse's CMRX Position: Q1 2024 in Review

Credit Suisse reduced its Chimerix, Inc. (CMRX) stake by 30% in Q1 2024, selling an estimated $41.6K and leaving 94,000 shares worth $99.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

Credit Suisse first reported a position in CMRX in Q4 2013 and has held it in 34 quarters since. The position peaked at $3.35M in Q2 2015. 78 funds tracked by Wall St. Rank hold CMRX as of Q1 2024.

Credit Suisse held 94,000 shares of Chimerix, Inc. worth $99.6K as of Q1 2024.
Credit Suisse sold 40,000 Chimerix, Inc. shares in Q1 2024, an estimated $41.6K.
Chimerix, Inc. made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2932 holding.
Credit Suisse first reported a position in Chimerix, Inc. in Q4 2013 and has held it in 34 quarters since.
Credit Suisse's Chimerix, Inc. position peaked at $3.35M in Q2 2015.
78 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.